4 cough syrups supplied by Indian pharmaceuticals linked to deaths in Gambia: WHO

WHO says four cough syrups from India’s Maiden Pharmaceuticals have been linked to deaths in Gambia.

WHO Director-General Tedros Adhanom Ghebreyesus has recommended that all countries identify and remove these products from circulation. (Photo: AP)

The World Health Organization (WHO) has issued a medical product alert for four contaminated drugs identified in The Gambia, which have been linked to serious kidney injuries and 66 deaths among children.

According to WHO, four medicines cough and cold syrups are manufactured in India by Maidan Pharmaceuticals Ltd. The World Health Organization said it is conducting further inquiries with the company and regulatory authorities in India.

WHO chief Dr Tedros Adhanom Ghebreyesus said in a media briefing, “The loss of these young lives is beyond heartbreaking for their families. The four drugs are cough and cold syrups manufactured by Maiden Pharmaceuticals Limited in India. WHO is conducting further investigations with the company and regulatory authorities in India.”

Although the contaminated products have so far been found only in The Gambia, they may have been distributed to other countries. WHO has recommended that all countries identify these products and remove them from circulation to prevent further harm to patients.

Read | Meet Svante Pabo, 2022 Nobel Prize Winner for Medicine. His father succeeded in 1982

— Ends —

Source link

What do you think?

Written by admin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Women’s T20 Asia Cup | Jemima, Deepti Do star as India thrash UAE by 104 runs

Hilary Swank announces she is pregnant with twins